Company Overview and News

Here's Why You Should Snap Up Urban Outfitters Right Now

15h zacks
A robust job market and rising disposable income spell hope for the retail industry. For investors who are on the hunt for stocks yielding high returns, Urban Outfitters, Inc. (URBN - Free Report) is a great option. The stock, which has a long-term expected growth rate of 12%, scaled to a 52-week high of $40.23 on Apr 18, eventually closing a tad lower at $39.68.
Upvote Downvote

Bed Bath & Beyond Inc. Is in Big Big Big Trouble

2018-04-18 investorplace
When it comes to being a deep-value investor, one has to be able to distinguish between good businesses whose stocks have been sold off unreasonably and stocks whose companies are value traps. That is particularly true when it comes to retail stocks. Once retail chains pass their mega-growth phase, their stocks decline significantly — and for good reason.
Upvote Downvote

5 Reasons Why Signet Jewelers Is A Possible Turnaround Candidate

2018-04-18 seekingalpha
Signet Jewelers (NYSE:SIG) is the largest diamond jewelry retailer in the world (Zales, Jared, Kay Jewelers and Piercing Pagoda) with over 2,500 stores worldwide. In the last year, SIG has seen sales fall somewhat and has initiated a new 3-year turnaround campaign that includes closing 200 stores.
Upvote Downvote

Kirkland's Looks Dull With Higher Operating & Promotion Costs

2018-04-18 zacks
Kirkland's, Inc. (KIRK - Free Report) has been in troubled waters for a while, thanks to higher operating and promotional costs. Consequently, this retailer of home decor products has been reporting losses for quite some time. These headwinds were sufficient to mar investors’ optimism on the Zacks Rank #5 (Strong Sell) stock that lost close to 13.4% in a year, while the industry declined 5%. Factors Affecting Kirkland Since Kirkland’s operates in an extremely consumer-driven environment, changes in spending habits adversely impact its performance.
Upvote Downvote

Tiffany Strategizes to Lift Sales, Innovates to Woo Buyers

2018-04-18 zacks
As competition is intensifying in the retail space, Tiffany & Co. (TIF - Free Report) is leaving no stone unturned to drive revenues. The company, which has a long-term expected earnings growth rate of 11.2%, is banking on several strategic initiatives to enhance customer base. The company's strategic endeavors have helped the stock to gain 8.5% compared with the industry’s decline of 1.2% in the past six months.
Upvote Downvote

Ollie's Bargain (OLLI) Makes a Mark: Stock Surges 18% YTD

2018-04-18 zacks
Ollie's Bargain Outlet Holdings, Inc.’s (OLLI - Free Report) business model of “buying cheap and selling cheap”, cost-containment efforts, focus on store productivity, sturdy comparable-store sales (comps) performance and expansion of customer reward program, Ollie's Army, fortify its position in the Consumer Staples space. These initiatives positioned the stock to augment both its top and bottom-line performance in the long run.
Upvote Downvote

Global Growth to Hit 7-Year High, Says IMF: 5 Picks

2018-04-18 zacks
The International Monetary Fund (IMF) has maintained its projections for global growth for the years of 2018 and 2019. According to its latest World Economic Outlook report, the upward revisions made in January, primarily to account for the impact of U.S. tax cuts, were kept unchanged. However, the IMF has also warned that extended trade related tensions could harm global growth over time.
Upvote Downvote

3 Reasons Home Depot Inc Stock Will Surge 30%

2018-04-17 investorplace
The broader market’s decline at the start of February has been a doozy for Home Depot Inc (NYSE:HD). After hitting a high near $207.50 in late-January, HD stock was pulverized down to $175 within just a few trading sessions. That 15.6% decline hardly seems fair, especially given that Home Depot stock still hasn’t recovered.
Upvote Downvote

What Does the March Tick-up in Sales Mean for Retailers?

2018-04-17 zacks
Bargain hunters are back on the streets buying furniture and appliances, and dining out, as U.S. retail sales rebounded sharply in the month of March, thus ending the streak of three straight declines. With strengthening labor market, tax reform and rising incomes Americans look much more confident now. Moreover, annual tax refunds are also likely to increase their propensity to consume. Clearly, consumer spending — one of the pivotal factors driving the economy — is likely to remain strong in the months ahead.
Upvote Downvote

Burlington Stores Adopts Initiatives to Fend Off Competition

2018-04-16 zacks
The U.S. economy is on a bumpy ride right now as investors are apprehensive about a trade war with China and rate hikes by the Fed. In such a scenario, investors can play safe with Burlington Stores, Inc. (BURL - Free Report) , which flaunts a long-term earnings growth rate of 18.7%.
Upvote Downvote

Trade Fears Hurt Consumer Sentiment: Should Retailers Worry?

2018-04-16 zacks
The Wall Street is juggling with various macro and micro issues at the moment, including U.S.-China trade dispute, Facebook data breach, apprehensions about three or more rate hikes by the Fed this year and latest being the airstrike on Syria. All these events have kept the market on tenterhooks with investors scurrying for safe havens. A clear reflection of these factors were visible in the recent outcome of the Consumer Sentiment data that declined from its 14-year high.
Upvote Downvote

Simon Says: 'The Cream Always Rises To The Top'

2018-04-16 seekingalpha
Simon's debt ratings are among the best unsecured debt ratings in the REIT industry, and this underscores the balance sheet strength.
Upvote Downvote

Macy's, Inc. (M) Sees Hammer Chart Pattern: Time to Buy?

2018-04-11 zacks
Macy's, Inc. (M - Free Report) has been struggling lately, but the selling pressure may be coming to an end soon. That is because M recently saw a Hammer Chart Pattern which can signal that the stock is nearing a bottom.
Upvote Downvote

Top Ranked Value Stocks to Buy for April 10th

2018-04-10 zacks
Here are four stocks with buy rank and strong value characteristics for investors to consider today, April 10th:
Upvote Downvote

Kohl's: The Retail Company Of The Future

2018-04-09 seekingalpha
Kohl's reported a great fourth-quarter release on March 1st. They reported a comparable sales increase of 6.3% and reported diluted earnings per share of $5.12.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 55616P104